Even seasoned executives can get so wrapped up in the P&L that they miss the operational behaviors driving the numbers.
That is exactly what happened with a Business Unit CEO I worked with. Each year, he judged his leaders by whether they deliver the results they committed to twelve months earlier. Anything else was a failure in his eyes.
One business consistently stood out. It hit its targets with clockwork precision. It had the smallest commercial footprint and the heaviest R&D spend in the portfolio. Its P&L was lopsided: low short-term revenue and high operating expenses driven by R&D. The CEO did not like the sales figures, but he trusted a leader who always delivered what was promised.
That trust was misplaced.
When we completed a Pyonnier R&D Audit, we went beneath the financials to examine how results were being achieved.
That is when the paradox became clear: the apparent performance was hiding an operational failure.
Because the cost base was dominated by R&D, management had a powerful lever. Whenever sales underperformed, they simply slowed the R&D work. Hiring was delayed. Prototypes were paused. Testing was deferred.
The P&L stayed on target. The R&D roadmap did not.
What looked like discipline was a double failure
❌ The current product missed its commercial objectives
❌ The next product was quietly pushed out to compensate
When the CEO saw this dynamic clearly, the realization was uncomfortable. He thought he was rewarding execution. He was incentivizing stagnation.
💡 Why R&D Audits Matter
This is why financial reports alone are insufficient in R&D heavy organizations.
A proper R&D audit bridges the gap between P&L statements and what is truly happening in the lab. It reveals whether teams are genuinely building future value or simply misallocating resources.
When a team says they are “on target,” leaders deserve to know which one it is.